Note. For cross-over trials (Basu et al. [67], Schell et al. [68], and Schumacher et al. [69]), participant characteristics are reported for the overall cohort because separate intervention-arm baseline values are not applicable. Duration refers to each treatment period; washout is stated in the Study Design cell. ACR: American College of Rheumatology.
JS: Conceptualization, Methodology, Data curation, Formal analysis, Investigation, Software, Validation, Visualization, Writing—original draft, Writing—review & editing. LB: Conceptualization, Methodology, Supervision, Validation, Writing—review & editing, Project administration. Both authors read and approved the submitted version.
Conflicts of interest
The authors declare that they have no conflicts of interest.
Ethical approval
Not applicable.
Consent to participate
Not applicable.
Consent to publication
Not applicable.
Availability of data and materials
The primary data for this meta-analysis were sourced online from databases listed in the methods. Referenced articles are accessible on PubMed, Scopus, and Web of Science. Additional supporting data are available from the corresponding author upon request.
Open Exploration maintains a neutral stance on jurisdictional claims in published institutional affiliations and maps. All opinions expressed in this article are the personal views of the author(s) and do not represent the stance of the editorial team or the publisher.
References
Felson DT, Lawrence RC, Dieppe PA, Hirsch R, Helmick CG, Jordan JM, et al. Osteoarthritis: new insights. Part 1: the disease and its risk factors.Ann Intern Med. 2000;133:635–46. [DOI] [PubMed]
He Y, Li Z, Alexander PG, Ocasio-Nieves BD, Yocum L, Lin H, et al. Pathogenesis of Osteoarthritis: Risk Factors, Regulatory Pathways in Chondrocytes, and Experimental Models.Biology (Basel). 2020;9:194. [DOI] [PubMed] [PMC]
Neogi T, Zhang Y. Epidemiology of osteoarthritis.Rheum Dis Clin North Am. 2013;39:1–19. [DOI] [PubMed] [PMC]
Li E, Tan J, Xu K, Pan Y, Xu P. Global burden and socioeconomic impact of knee osteoarthritis: a comprehensive analysis.Front Med (Lausanne). 2024;11:1323091. [DOI] [PubMed] [PMC]
Neogi T. The epidemiology and impact of pain in osteoarthritis.Osteoarthritis Cartilage. 2013;21:1145–53. [DOI] [PubMed] [PMC]
Stefanik JJ, Guermazi A, Roemer FW, Peat G, Niu J, Segal NA, et al. Changes in patellofemoral and tibiofemoral joint cartilage damage and bone marrow lesions over 7 years: the Multicenter Osteoarthritis Study.Osteoarthritis Cartilage. 2016;24:1160–6. [DOI] [PubMed] [PMC]
Lawrence RC, Felson DT, Helmick CG, Arnold LM, Choi H, Deyo RA, et al.; National Arthritis Data Workgroup. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II.Arthritis Rheum. 2008;58:26–35. [DOI] [PubMed] [PMC]
Suri P, Morgenroth DC, Hunter DJ. Epidemiology of osteoarthritis and associated comorbidities.PM R. 2012;4:S10–9. [DOI] [PubMed]
Heidari B. Knee osteoarthritis prevalence, risk factors, pathogenesis and features: Part I.Caspian J Intern Med. 2011;2:205–12. [PubMed] [PMC]
GBD 2021 Osteoarthritis Collaborators. Global, regional, and national burden of osteoarthritis, 1990-2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021.Lancet Rheumatol. 2023;5:e508–22. [DOI] [PubMed] [PMC]
Richard MJ, Driban JB, McAlindon TE. Pharmaceutical treatment of osteoarthritis.Osteoarthritis Cartilage. 2023;31:458–66. [DOI] [PubMed]
Jüni P, Hari R, Rutjes AW, Fischer R, Silletta MG, Reichenbach S, et al. Intra-articular corticosteroid for knee osteoarthritis.Cochrane Database Syst Rev. 2015;2015:CD005328. [DOI] [PubMed] [PMC]
Fazio A, Di Martino A, Brunello M, Traina F, Marvi MV, Mazzotti A, et al. The involvement of signaling pathways in the pathogenesis of osteoarthritis: An update.J Orthop Translat. 2024;47:116–24. [DOI] [PubMed] [PMC]
O’Neil CK, Hanlon JT, Marcum ZA. Adverse effects of analgesics commonly used by older adults with osteoarthritis: focus on non-opioid and opioid analgesics.Am J Geriatr Pharmacother. 2012;10:331–42. [DOI] [PubMed] [PMC]
Coxib and traditional NSAID Trialists’ (CNT) Collaboration; Bhala N, Emberson J, Merhi A, Abramson S, Arber N, Baron JA, et al. Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials.Lancet. 2013;382:769–79. [DOI] [PubMed] [PMC]
Kallivayalil RA. Are we over-dependent on pharmacotherapy?Indian J Psychiatry. 2008;50:7–9. [DOI] [PubMed] [PMC]
Chow YY, Chin KY. The Role of Inflammation in the Pathogenesis of Osteoarthritis.Mediators Inflamm. 2020;2020:8293921. [DOI] [PubMed] [PMC]
Saberi Hosnijeh F, Siebuhr AS, Uitterlinden AG, Oei EH, Hofman A, Karsdal MA, et al. Association between biomarkers of tissue inflammation and progression of osteoarthritis: evidence from the Rotterdam study cohort.Arthritis Res Ther. 2016;18:81. [DOI] [PubMed] [PMC]
Krakowski P, Rejniak A, Sobczyk J, Karpiński R. Cartilage Integrity: A Review of Mechanical and Frictional Properties and Repair Approaches in Osteoarthritis.Healthcare (Basel). 2024;12:1648. [DOI] [PubMed] [PMC]
Karpiński R, Prus A, Baj J, Radej S, Prządka M, Krakowski P, et al. Articular Cartilage: Structure, Biomechanics, and the Potential of Conventional and Advanced Diagnostics.Appl Sci. 2025;15:6896. [DOI]
Hannani MT, Thudium CS, Karsdal MA, Ladel C, Mobasheri A, Uebelhoer M, et al. From biochemical markers to molecular endotypes of osteoarthritis: a review on validated biomarkers.Expert Rev Mol Diagn. 2024;24:23–38. [DOI] [PubMed]
Jenei-Lanzl Z, Zaucke F. Osteoarthritis year in review 2024: Biology.Osteoarthritis Cartilage. 2025;33:58–66. [DOI] [PubMed]
Jenei-Lanzl Z, Maurer S, Brenner RE, Zaucke F, Fuchs M, Riegger J. Emerging concepts and challenges in the development of disease-modifying osteoarthritis drugs - a more refined perspective.Arch Pharm Res. 2025;48:467–94. [DOI] [PubMed] [PMC]
Doss F, Menard J, Hauschild M, Kreutzer HJ, Mittlmeier T, Müller-Steinhardt M, et al. Elevated IL-6 levels in the synovial fluid of osteoarthritis patients stem from plasma cells.Scand J Rheumatol. 2007;36:136–9. [DOI] [PubMed]
Mabey T, Honsawek S. Cytokines as biochemical markers for knee osteoarthritis.World J Orthop. 2015;6:95–105. [DOI] [PubMed] [PMC]
Rose BJ, Kooyman DL. A Tale of Two Joints: The Role of Matrix Metalloproteases in Cartilage Biology.Dis Markers. 2016;2016:4895050. [DOI] [PubMed] [PMC]
Sokolove J, Lepus CM. Role of inflammation in the pathogenesis of osteoarthritis: latest findings and interpretations.Ther Adv Musculoskelet Dis. 2013;5:77–94. [DOI] [PubMed] [PMC]
Pozgan U, Caglic D, Rozman B, Nagase H, Turk V, Turk B. Expression and activity profiling of selected cysteine cathepsins and matrix metalloproteinases in synovial fluids from patients with rheumatoid arthritis and osteoarthritis.Biol Chem. 2010;391:571–9. [DOI] [PubMed]
Jansen NW, Roosendaal G, Hooiveld MJ, Bijlsma JW, van Roon JA, Theobald M, et al. Interleukin-10 protects against blood-induced joint damage.Br J Haematol. 2008;142:953–61. [DOI] [PubMed]
Hart PH, Ahern MJ, Smith MD, Finlay-Jones JJ. Regulatory effects of IL-13 on synovial fluid macrophages and blood monocytes from patients with inflammatory arthritis.Clin Exp Immunol. 1995;99:331–7. [DOI] [PubMed] [PMC]
Morales-Ivorra I, Romera-Baures M, Roman-Viñas B, Serra-Majem L. Osteoarthritis and the Mediterranean Diet: A Systematic Review.Nutrients. 2018;10:1030. [DOI] [PubMed] [PMC]
Asadi S, Grafenauer S, Burley CV, Fitzgerald C, Humburg P, Parmenter BJ. The effectiveness of dietary intervention in osteoarthritis management: a systematic review and meta-analysis of randomized clinical trials.Eur J Clin Nutr. 2025;79:959–71. [DOI] [PubMed] [PMC]
Cooper I, Brukner P, Devlin BL, Reddy AJ, Fulton M, Kemp JL, et al. An anti-inflammatory diet intervention for knee osteoarthritis: a feasibility study.BMC Musculoskelet Disord. 2022;23:47. [DOI] [PubMed] [PMC]
Zheng J, Zhou Y, Li S, Zhang P, Zhou T, Xu DP, et al. Effects and Mechanisms of Fruit and Vegetable Juices on Cardiovascular Diseases.Int J Mol Sci. 2017;18:555. [DOI] [PubMed] [PMC]
Clegg DO, Reda DJ, Harris CL, Klein MA, O’Dell JR, Hooper MM, et al. Glucosamine, chondroitin sulfate, and the two in combination for painful knee osteoarthritis.N Engl J Med. 2006;354:795–808. [DOI] [PubMed]
Kim LS, Axelrod LJ, Howard P, Buratovich N, Waters RF. Efficacy of methylsulfonylmethane (MSM) in osteoarthritis pain of the knee: a pilot clinical trial.Osteoarthritis Cartilage. 2006;14:286–94. [DOI] [PubMed]
Usha PR, Naidu MU. Randomised, Double-Blind, Parallel, Placebo-Controlled Study of Oral Glucosamine, Methylsulfonylmethane and their Combination in Osteoarthritis.Clin Drug Investig. 2004;24:353–63. [DOI] [PubMed]
Messina OD, Vidal Wilman M, Vidal Neira LF. Nutrition, osteoarthritis and cartilage metabolism.Aging Clin Exp Res. 2019;31:807–13. [DOI] [PubMed]
Arden NK, Cro S, Sheard S, Doré CJ, Bara A, Tebbs SA, et al. The effect of vitamin D supplementation on knee osteoarthritis, the VIDEO study: a randomised controlled trial.Osteoarthritis Cartilage. 2016;24:1858–66. [DOI] [PubMed] [PMC]
McAlindon T, LaValley M, Schneider E, Nuite M, Lee JY, Price LL, et al. Effect of vitamin D supplementation on progression of knee pain and cartilage volume loss in patients with symptomatic osteoarthritis: a randomized controlled trial.JAMA. 2013;309:155–62. [DOI] [PubMed] [PMC]
Jin X, Jones G, Cicuttini F, Wluka A, Zhu Z, Han W, et al. Effect of Vitamin D Supplementation on Tibial Cartilage Volume and Knee Pain Among Patients With Symptomatic Knee Osteoarthritis: A Randomized Clinical Trial.JAMA. 2016;315:1005–13. [DOI] [PubMed]
Altman RD, Marcussen KC. Effects of a ginger extract on knee pain in patients with osteoarthritis.Arthritis Rheum. 2001;44:2531–8. [DOI] [PubMed]
Heidari-Beni M, Moravejolahkami AR, Gorgian P, Askari G, Tarrahi MJ, Bahreini-Esfahani N. Herbal formulation “turmeric extract, black pepper, and ginger” versus Naproxen for chronic knee osteoarthritis: A randomized, double-blind, controlled clinical trial.Phytother Res. 2020;34:2067–73. [DOI] [PubMed]
Bolognesi G, Belcaro G, Feragalli B, Cornelli U, Cotellese R, Hu S, et al. Movardol® (N-acetylglucosamine, Boswellia serrata, ginger) supplementation in the management of knee osteoarthritis: preliminary results from a 6-month registry study.Eur Rev Med Pharmacol Sci. 2016;20:5198–204. [PubMed]
Sinclair J, Bottoms L, Dillon S, Allan R, Shadwell G, Butters B. Effects of Montmorency Tart Cherry and Blueberry Juice on Cardiometabolic and Other Health-Related Outcomes: A Three-Arm Placebo Randomized Controlled Trial.Int J Environ Res Public Health. 2022;19:5317. [DOI] [PubMed] [PMC]
Nemzer B, Kalita D, Yashin AY, Yashin YI. Chemical Composition and Polyphenolic Compounds of Red Wines: Their Antioxidant Activities and Effects on Human Health—A Review.Beverages. 2021;8:1. [DOI]
Wallace TC, Slavin M, Frankenfeld CL. Systematic Review of Anthocyanins and Markers of Cardiovascular Disease.Nutrients. 2016;8:32. [DOI] [PubMed] [PMC]
Ogur R, Istanbulluoglu H, Korkmaz A, Barla A, Tekbas OF, Oztas E. Report: investigation of anti-cancer effects of cherry in vitro.Pak J Pharm Sci. 2014;27:587–92. [PubMed]
Desai T, Roberts M, Bottoms L. Effects of Montmorency tart cherry supplementation on cardio-metabolic markers in metabolic syndrome participants: A pilot study.J Funct Foods. 2019;57:286–98. [DOI]
Chai SC, Davis K, Zhang Z, Zha L, Kirschner KF. Effects of Tart Cherry Juice on Biomarkers of Inflammation and Oxidative Stress in Older Adults.Nutrients. 2019;11:228. [DOI] [PubMed] [PMC]
Johnson SA, Figueroa A, Navaei N, Wong A, Kalfon R, Ormsbee LT, et al. Daily blueberry consumption improves blood pressure and arterial stiffness in postmenopausal women with pre- and stage 1-hypertension: a randomized, double-blind, placebo-controlled clinical trial.J Acad Nutr Diet. 2015;115:369–77. [DOI] [PubMed]
Lynn A, Mathew S, Moore CT, Russell J, Robinson E, Soumpasi V, et al. Effect of a tart cherry juice supplement on arterial stiffness and inflammation in healthy adults: a randomised controlled trial.Plant Foods Hum Nutr. 2014;69:122–7. [DOI] [PubMed]
Sinclair J, McLaughlin G, Allan R, Brooks-Warburton J, Lawson C, Goh S, et al. Health Benefits of Montmorency Tart Cherry Juice Supplementation in Adults with Mild to Moderate Ulcerative Colitis; A Placebo Randomized Controlled Trial.Life (Basel). 2025;15:306. [DOI] [PubMed] [PMC]
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. Updating guidance for reporting systematic reviews: development of the PRISMA 2020 statement.J Clin Epidemiol. 2021;134:103–12. [DOI] [PubMed]
Higgins JP, Thomas J, Chandler J, Cumpston M, Li T, Page M. A Cochrane handbook for systematic reviews of interventions. John Wiley & Sons; 2019.
Hedges LV, Olkin I. Statistical methods for meta-analysis. Academic Press; 2014.
Brydges CR. Effect Size Guidelines, Sample Size Calculations, and Statistical Power in Gerontology.Innov Aging. 2019;3:igz036. [DOI] [PubMed] [PMC]
Follmann D, Elliott P, Suh I, Cutler J. Variance imputation for overviews of clinical trials with continuous response.J Clin Epidemiol. 1992;45:769–73. [DOI] [PubMed]
Veroniki AA, Jackson D, Viechtbauer W, Bender R, Bowden J, Knapp G, et al. Methods to estimate the between-study variance and its uncertainty in meta-analysis.Res Synth Methods. 2016;7:55–79. [DOI] [PubMed] [PMC]
Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test.BMJ. 1997;315:629–34. [DOI] [PubMed] [PMC]
Guyatt G, Oxman AD, Akl EA, Kunz R, Vist G, Brozek J, et al. GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables.J Clin Epidemiol. 2011;64:383–94. [DOI] [PubMed]
Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials.BMJ. 2019;366:l4898. [DOI] [PubMed]
Du C, Smith A, Avalos M, South S, Crabtree K, Wang W, et al. Blueberries Improve Pain, Gait Performance, and Inflammation in Individuals with Symptomatic Knee Osteoarthritis.Nutrients. 2019;11:290. [DOI] [PubMed] [PMC]
Basu A, Kurien BT, Tran H, Byrd B, Maher J, Schell J, et al. Strawberries decrease circulating levels of tumor necrosis factor and lipid peroxides in obese adults with knee osteoarthritis.Food Funct. 2018;9:6218–26. [DOI] [PubMed] [PMC]
Schell J, Scofield RH, Barrett JR, Kurien BT, Betts N, Lyons TJ, et al. Strawberries Improve Pain and Inflammation in Obese Adults with Radiographic Evidence of Knee Osteoarthritis.Nutrients. 2017;9:949. [DOI] [PubMed] [PMC]
Schumacher HR, Pullman-Mooar S, Gupta SR, Dinnella JE, Kim R, McHugh MP. Randomized double-blind crossover study of the efficacy of a tart cherry juice blend in treatment of osteoarthritis (OA) of the knee.Osteoarthritis Cartilage. 2013;21:1035–41. [DOI] [PubMed]
Kuehl KS, Elliot DL, Sleigh AE, Smith JL. Efficacy of tart cherry juice to reduce inflammation biomarkers among women with inflammatory osteoarthritis (OA).J Food Stud. 2012;1:14–25. [DOI]
Ghoochani N, Karandish M, Mowla K, Haghighizadeh MH, Jalali MT. The effect of pomegranate juice on clinical signs, matrix metalloproteinases and antioxidant status in patients with knee osteoarthritis.J Sci Food Agric. 2016;96:4377–81. [DOI] [PubMed]
Nejadhosseinian M, Djalalinia S, Haerian H, Alikhani M, Mansour A, Mousavian AH, et al. The effects of antioxidants on knee osteoarthritis: A systematic review and meta-analysis.Front Nutr. 2022;9:1026450. [DOI] [PubMed] [PMC]
Wiegertjes R, van de Loo FAJ, Blaney Davidson EN. A roadmap to target interleukin-6 in osteoarthritis.Rheumatology (Oxford). 2020;59:2681–94. [DOI] [PubMed] [PMC]
Liao Y, Ren Y, Luo X, Mirando AJ, Long JT, Leinroth A, et al. Interleukin-6 signaling mediates cartilage degradation and pain in posttraumatic osteoarthritis in a sex-specific manner.Sci Signal. 2022;15:eabn7082. [DOI] [PubMed] [PMC]
Pereira D, Peleteiro B, Araújo J, Branco J, Santos RA, Ramos E. The effect of osteoarthritis definition on prevalence and incidence estimates: a systematic review.Osteoarthritis Cartilage. 2011;19:1270–85. [DOI] [PubMed]
McAlindon TE, Bannuru RR, Sullivan MC, Arden NK, Berenbaum F, Bierma-Zeinstra SM, et al. OARSI guidelines for the non-surgical management of knee osteoarthritis.Osteoarthritis Cartilage. 2014;22:363–88. [DOI] [PubMed]
Hochberg MC, Altman RD, April KT, Benkhalti M, Guyatt G, McGowan J, et al.; American College of Rheumatology. American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee.Arthritis Care Res (Hoboken). 2012;64:465–74. [DOI] [PubMed]
Kan HS, Chan PK, Chiu KY, Yan CH, Yeung SS, Ng YL, et al. Non-surgical treatment of knee osteoarthritis.Hong Kong Med J. 2019;25:127–33. [DOI] [PubMed]